Spinal Muscular Atrophy (SMA) in the Therapeutic Era

被引:0
作者
Melissa Gibbons
Anne Stratton
Julie Parsons
机构
[1] University of Colorado Anschutz Medical Campus/Children’s Hospital Colorado,
来源
Current Genetic Medicine Reports | 2019年 / 7卷
关键词
Spinal muscular atrophy; SMA; Gene therapy; Genetic counseling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:162 / 167
页数:5
相关论文
共 260 条
[1]  
Prior TW(2010)Perspectives and diagnostic considerations in spinal muscular atrophy Genet Med. 12 145-152
[2]  
Russman BS(2007)Spinal muscular atrophy: clinical classification and disease heterogeneity J Child Neurol 22 946-951
[3]  
Wirth B(2000)An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA) Hum Mutat 15 228-237
[4]  
Kolb SJ(2011)Spinal muscular atrophy: a timely review Arch Neurol 68 979-984
[5]  
Kissel JT(2012)Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens Eur J Hum Genet 20 27-32
[6]  
Sugarman EA(1997)Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7 Neurogenetics. 1 141-147
[7]  
Nagan N(2008)Carrier screening for spinal muscular atrophy Genet Med. 10 840-842
[8]  
Zhu H(2018)Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases Neuromuscul Disord 28 208-215
[9]  
Akmaev VR(2018)Gene therapy for spinal muscular atrophy: an emerging treatment option for a devastating disease J Manag Care Spec Pharm 24 S3-S16
[10]  
Zhou Z(2002)Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2 Genet Med. 4 20-26